GlassScriptPhysician profile
Latrese Andre
NPI 1821196924
$2,221.67
in general payments reported to CMS, 2019-2025
11 companies · $843 in 2025
The $843 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.61 · 2022: $375 · 2023: $756 · 2024: $194 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $944 · Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $944.24 |
| Food and Beverage | $848.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,121.60 | 2023-2025 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $216.21 | 2021-2022 | |
| Tactile Systems Technology INC | $215.14 | 2025 | Nimbl, Flexitouch Plus |
| Bard Peripheral Vascular, INC. | $182.14 | 2025 | Venovo |
| Galderma Laboratories, L.P. | $130.10 | 2022-2023 | |
| Merz North America, INC. | $127.76 | 2023 | Xeomin |
| Stability Biologics, LLC | $98.49 | 2022 | |
| Organogenesis INC. | $64.16 | 2022-2025 | Affinity |
| Medtronic, INC. | $22.26 | 2023 | Venaseal |
| Kci USA, INC. | $22.23 | 2022 | |
| Aroa Biosurgery Incorporated | $21.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latrese Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.